Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The human Melatonin Receptor MT1 is a GPCR crucially involved in regulating circadian rhythms—especially REM sleep—and modulating mood through inhibitory signaling pathways primarily mediated by Gi proteins. Its distinct anatomical distribution underlies its specialized physiological roles. Ongoing research aims at developing selective drugs targeting this receptor subtype for improved treatment outcomes across multiple neuropsychiatric conditions.
Agonist binding inhibits adenylate cyclase activity, leading to decreased intracellular cAMP levels and subsequent downstream effects.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melatonin Receptor MT1 (MT1).